I think the selling is exhausted and it's only upside from here...

I think the selling is exhausted and it's only upside from here with the company kicking off it's roadshow today in Perth and at a Biotech lunch along with Oncasil (OSL), Cellmed (CDY) presenting to 120 Bio focussed Perth brokers and SI's that I will be attending.

I am not concerned with the IMU holding and am glad that we realised some real monet for our holding as it appears to be a shell now, from my point of view.

The Rhinomed name now cements our focus on Nasal technology innovation and gives the company a clear focus for delivery.

No doubt the November roll out is going to give the company sufficient time to make the impact of the product launch all encompassing with Jane the key player here.

This roadshow is going around the country and will get the attention of astute broking houses.

Good luck and please DYOR